Cronos Australia
Cronos Australia is committed to providing Australian patients access to the highest quality plant-based products, as well as supplying export markets globally. Our vision is to become a leading health and wellness company in the Asia Pacific region with a portfolio of cannabinoid products.
Our business model is underpinned by innovative product and brand development, outsourced manufacturing and distribution for Australia and target export markets. In addition, Cronos Australia’s operations are delivered via a group of strategically aligned entities, including CDA Clinics, Adaya, Cannadoc, Burleigh Heads Cannabis (BHC), and BHC’s CanView.
Cronos Australia is also a proud founding member of the Emerging Therapeutics Association of Australia.
Our Values
We’re Good Humans
We highly value true integrity and honesty. We’re transparent and respectful and we act with respect for each other. We exhibit true authenticity and humility.
We’re Productive
We work hard in a productive and efficient way and are accountable to our commitments.
We Cultivate Innovation
We’re curious, science-minded and research orientated. We display ingenuity and challenge the status quo. We don’t just do things because that’s how they’ve always been done.
We Strive for Excellence
We deliver excellence in products, clinical outcomes, patient care, customer service and everything we do. We are continuously striving to be better.
We Operate Ethically
We’re compliant and ethical players in a highly regulated industry who don’t take risks for short term gains. We are risk savvy and always mitigate large risks with creative but highly compliant solutions.
Cronos Australia is listed on the ASX, under the code CAU.
Our Board
The primary role of our Board is to protect and enhance medium to long term shareholder value through the provision of strategic direction and corporate governance of Cronos Australia.
Bringing a wealth of knowledge and experience, our Board carries a diverse background of expertise and is proudly comprised of 60% female representation.
Pictured left to right: Thomas Howitt (Company Secretary), Dr Simone Scovell, Dr Marcia Walker, Rodney D. Cocks, Jenelle Frewen, Guy Headley.
LEADERSHIP - Board
Director
Rodney D. Cocks CSM
Qualifications: BCom (Melb.), LLB (QUT), MBA (Wharton), MPA (Harvard), GAICD
Rodney Cocks CSM was appointed Executive Director and Chief Executive Officer of Cronos Australia on 27 September 2018. He is a Director of NewSouthern Capital Pty. Ltd., a private equity firm he co-founded. Prior to joining CAL, he was a member of the Senior Leadership Team at Linfox and was a Consultant at the Boston Consulting Group. Rodney served on the Counter Narcotics Team of the British Embassy in Afghanistan and with the United Nations in Afghanistan, Sri Lanka, Pakistan and Iraq and started his career as an Infantry Officer in the Australian Army. Rodney holds a BCom from the University of Melbourne, LLB from the Queensland University of Technology, MBA from the Wharton School, University of Pennsylvania, MPA from the Harvard Kennedy School, Harvard University and is a Graduate of the Australian Institute of Company Directors and the Royal Military College, Duntroon. He is an admitted Lawyer to the Supreme Court of New South Wales, was a Fellow at Harvard University and named the 2005 Victorian Australian of the Year. In 2003, Rodney was awarded a Conspicuous Service Medal for his actions in the aftermath of the 2002 Bali bombings.
Director
Guy R. Headley
Guy Headley was appointed Executive Director and Chief Commercial Officer of Cronos Australia on 16 December 2021. Guy has operated in the Australian Medical Cannabis space since 2016. He is a founding director of CDA Health Pty. Ltd. and has acted as a director of Burleigh Heads Cannabis Pty. Ltd. over the last five years. He brings a wealth of knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director and Chair of the Emerging Therapeutics Association of Australia.
Director
Dr. Marcia A.M. Walker
Qualifications: BHB, MBChB, FRNZCGP
Other responsibilities: Chair of Audit and Risk Committee, Member of Nomination and Remuneration Committee
Dr. Marcia Walker was appointed Non-Executive Director of Cronos Australia on 16 December 2021. Marcia brings significant experience in Medical Governance and currently serves on the board of the New Zealand Medical Association, is a member of the General Practitioner Council of the NZMA, a member of the Medicines Classifications Committee for the Ministry of Health NZ and acts as a Medical Examiner for the Royal New Zealand College of General Practitioners. Previously, she acted as a Medical Advisor to the Rua BioScience (formerly Hikurangi Hemp Company) and Treasurer for the New Zealand Resident Doctors Association. Marcia received a Bachelor of Medicine and a Bachelor of Surgery / Chirurgery from the University of Auckland and is a fellow of the Royal New Zealand College of General Practitioners. She also acts as the Medical Director of The Cosmetic Clinic New Zealand.
Independent Non-Executive Director
Jenelle Frewen
Jenelle is an accomplished government strategist and adviser with more than two decades’ experience spanning complex policy development and implementation in highly regulated industries. She has led several federal and state political campaigns, and advised a range of business clients on public affairs and regulatory policy.
Jenelle has experience working at all three levels of government in Australia and in new areas of policymaking in technology, broadband and cyber. She also spent time in her early career working as a communications and media adviser in the private sector in Australia, and was a senior aide in municipal government in the United States. Jenelle is currently Principal Consultant with the Canberra-based advisory firm, Precision Public Affairs. Jenelle obtained a Bachelor of Economics and a Bachelor of Arts with Honours from Monash University. She also holds a post-graduate diploma in Governance and Public Policy.
Independent Non-Executive Director
Dr. Simone Scovell
Simone is the Founder and CEO of TOTIUM, a multi-national B2B med-tech and health services company delivering quality, affordable and tailored healthcare solutions for some of the world’s most iconic companies. She is a Specialist Occupational Physician and Fellow of Medicine within the Royal Australasian College of Physicians who brings a wealth of experience in Commercial, Clinical and Health Data Governance. Simone is currently a Nominee Representative on behalf of the Commonwealth Health Minister to sit as a Non-Executive Board Director for the Australian Institute of Health and Welfare (AIHW), further sitting as an AIHW Director of Risk, Audit and Finance. She is a Non-Executive Director for the Whiddon Group, an award-winning, not-for-profit Aged Care provider where she Chairs both the ICT and Clinical Governance Committees.
Simone is also a former Director of the Royal Australasian College of Physicians (RACP), sitting as Risk Director during that tenure; also a Founding member of the RACP’s Physician Health and Wellbeing Reference Group. Simone holds triple Degrees in Medicine, Surgery and Medical Science from Sydney University, is a Master of Occupational and Environmental Health (Monash University) and is currently completing an Associate Degree in Artificial Intelligence in Healthcare (Stanford University School of Medicine, USA). She was voted Doctor of the Year by her peers in 2005; her final year working as the Hospital’s in-house Resident surgeon in Cardiothoracic Surgery at St. Vincent’s Hospital, Sydney.
Management
Rodney D. Cocks CSM
Qualifications: BCom (Melb.), LLB (QUT), MBA (Wharton), MPA (Harvard), GAICD
Rodney Cocks CSM was appointed Executive Director and Chief Executive Officer of Cronos Australia on 27 September 2018. He is a Director of NewSouthern Capital Pty. Ltd., a private equity firm he co-founded. Prior to joining CAL, he was a member of the Senior Leadership Team at Linfox and was a Consultant at the Boston Consulting Group. Rodney served on the Counter Narcotics Team of the British Embassy in Afghanistan and with the United Nations in Afghanistan, Sri Lanka, Pakistan and Iraq and started his career as an Infantry Officer in the Australian Army. Rodney holds a BCom from the University of Melbourne, LLB from the Queensland University of Technology, MBA from the Wharton School, University of Pennsylvania, MPA from the Harvard Kennedy School, Harvard University and is a Graduate of the Australian Institute of Company Directors and the Royal Military College, Duntroon. He is an admitted Lawyer to the Supreme Court of New South Wales, was a Fellow at Harvard University and named the 2005 Victorian Australian of the Year. In 2003, Rodney was awarded a Conspicuous Service Medal for his actions in the aftermath of the 2002 Bali bombings.
Management
Thomas G. Howitt
Qualifications: BCom (University of Western Australia), CA, AICPA, AGIA, ACIS, CTA
Thomas Howitt was appointed as the Chief Financial Officer of CAL on 3 December 2018 and as Company Secretary on 14 August 2020. Prior to joining the Company, he was the Chief Financial Officer of Global Kinetics Corporation, a pre-IPO life sciences company, Chief Financial Officer/ Company Secretary of Simavita (ASX:SVA, TSX-V:SV) a digital healthcare company, Chief Financial Officer/Company Secretary of Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE) a genetic testing company, and several other listed life science companies. Prior to that, Thomas worked in the investment banking industry and was a Taxation Manager at EY. Thomas is a member of the Victorian Branch Committee of AusBiotech and a member of the CCRM Australia Industry Interface Committee based at Monash University
Management
Guy R. Headley
Guy Headley was appointed Executive Director and Chief Commercial Officer of Cronos Australia on 16 December 2021. Guy has operated in the Australian Medical Cannabis space since 2016. He is a founding director of CDA Health Pty. Ltd. and has acted as a director of Burleigh Heads Cannabis Pty. Ltd. over the last five years. He brings a wealth of knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director and Chair of the Emerging Therapeutics Association of Australia.
Management
Ryan Tattle
Ryan was appointed National Distribution manager of Cronos Australia on 16 December 2021. As an early member of CDA Health, Ryan has an extensive knowledge of the medical cannabis industry with a strict focus on execution – backed by a passion for commercial strategy, distribution, and regulatory compliance. Ryan has played a key role in the growth of the Burleigh Heads Cannabis distribution operation and expansion, as well as being one of the driving forces behind the development, evolution and rollout of the CanView platform. Prior to working within the cannabis space, Ryan gained extensive start-up experience in a range of industries, which included an American based, medical focused product development company where he oversaw a global supply chain, clinical trials and a national distribution network. He has previously developed and run an online multi-sided marketplace where he inherited the ability to implement his deep understanding of the intricacies around platform and ecosystem strategy to the organisation today. Ryan is also a director of his own registered charity; a qualified helicopter pilot and superyacht captain having covered over 50,000 nautical miles.
Management
Hendrik Gunter
My name is Hendrick Gunter, nice to meet you! I am originally from South Africa and recently moved to Australia.
After completing my bachelor’s degree in Biochemistry and Botany I have worked over 11 years in the pharmaceutical industry in different portfolios and roles. During the last few years, I have put a lot of emphasis on skills development and this experience has equipped me to look at compliant and innovative ways on how to grow the business looking into the future. I am now joining the sales team to assist with guidance and focus on strategic imperatives to get the best from our customers. I cannot wait to see the successes we as a team will achieve.
Outside of work I love to spend time with family and friends. You’ll often find me at the beach and in the bush enjoying the outdoors.
At the office, I will be focused on supporting the sales team, key accounts and anything necessary to support the business. I am looking forward to learning from my team and to create an inclusive environment for the team to grow and achieve set goals. I look forward to meeting and working with you all.